2 ms·
"The team, led by Jay C. Fournier and Robert J. DeRubeis of the University of Pennsylvania, found that compared with placebos, the drugs caused a much steeper r
by tokenadult 17y ago
"The team, led by Jay C. Fournier and Robert J. DeRubeis of the University of Pennsylvania, found that compared with placebos, the drugs caused a much steeper reduction in symptoms of severe depression (cases scoring 25 or higher on a standard scale of severity, putting them in the top quarter of the sample). Patients with scores of less than 25 got little or no added benefit from the medications.
"'We were able to give an overall estimate of effectiveness for the first time in this more moderate severity range, from 14 to 20 on the scale, in which there’s no question that doctors would likely consider prescribing medication,' Dr. DeRubeis said."
This is good that the study used a depression rating scale to categorize patients in a way that shows which patients are most likely to benefit from drug treatments. As the article notes, there are other approaches to treating depression, and the friendly attention of doctors in a clinical trial is beneficial enough in itself that drugs are hard put to beat placebos except for patients who have more severe depression. Many other people bothered by depression may gain much more benefit from cognitive therapy.